Young Kim
-
Discovery of new “checkpoint” points to new cancer immunotherapy option
An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer. Read MoreFeb 21, 2019
-
Vanderbilt Biophotonics Center collaboration seeks earlier diagnosis of throat cancer
Vanderbilt researchers in the schools of engineering and medicine are exploring the feasibility of using Raman spectroscopy for early detection of HPV-related cancers of the throat in order to reduce the need for biopsies and to offer less intensive therapies. Read MoreNov 28, 2018
-
Six Vanderbilt physicians honored by medical societies
Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are: Read MoreMay 3, 2018